Teachers Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.36M Buy
18,812
+619
+3% +$76.9K ﹤0.01% 1885
2018
Q4
$2.05M Buy
18,193
+5,013
+38% +$776K ﹤0.01% 1831
2018
Q3
$2.82M Buy
13,180
+1,448
+12% +$363K ﹤0.01% 1780
2018
Q2
$3.28M Buy
11,732
+2,582
+28% +$453K ﹤0.01% 1657
2018
Q1
$1.07M Buy
9,150
+1,876
+26% +$232K ﹤0.01% 2180
2017
Q4
$668K Buy
7,274
+2,403
+49% +$137K ﹤0.01% 2432
2017
Q3
$219K Hold
4,871
﹤0.01% 2952
2017
Q2
$79K Buy
+4,871
New +$76.1K ﹤0.01% 3072
2015
Q4
Sell
-4,001
Closed -$244K 3109
2015
Q3
$244K Hold
4,001
﹤0.01% 2806
2015
Q2
$312K Buy
4,001
+1,170
+41% +$98.2K ﹤0.01% 2809
2015
Q1
$192K Buy
2,831
+535
+23% +$45.9K ﹤0.01% 2894
2014
Q4
$213K Buy
2,296
+39
+2% +$4.03K ﹤0.01% 2874
2014
Q3
$238K Hold
2,257
﹤0.01% 2802
2014
Q2
$323K Buy
2,257
+102
+5% +$14.9K ﹤0.01% 2696
2014
Q1
$325K Buy
2,155
+273
+15% +$53.8K ﹤0.01% 2635
2013
Q4
$345K Buy
1,882
+222
+13% +$40.7K ﹤0.01% 2582
2013
Q3
$367K Hold
1,660
﹤0.01% 2506
2013
Q2
$290K Buy
+1,660
New +$433K ﹤0.01% 2558

Other funds holding MDGL

Teachers Advisors's MDGL Position: Q1 2019 in Review

Teachers Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 3.4% in Q1 2019, buying an estimated $76.9K and bringing the position to 18,812 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

Teachers Advisors first reported a position in MDGL in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.28M in Q2 2018. 135 funds tracked by Wall St. Rank hold MDGL as of Q1 2019.

  • Teachers Advisors held 18,812 shares of Madrigal Pharmaceuticals worth $2.36M as of Q1 2019.
  • Teachers Advisors bought 619 Madrigal Pharmaceuticals shares in Q1 2019, an estimated $76.9K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1885 holding.
  • Teachers Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • Teachers Advisors's Madrigal Pharmaceuticals position peaked at $3.28M in Q2 2018.
  • 135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.